{
    "clinical_study": {
        "@rank": "162967", 
        "arm_group": [
            {
                "arm_group_label": "Nepicastat", 
                "arm_group_type": "Active Comparator", 
                "description": "Nepicastat 120mg and 100mg riboflavin (once per day) for 11 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo capsule containing 100mg riboflavin (once per day) for 11 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate the safety and efficacy of Nepicastat in\n      improving the number of subjects that achieve abstinence from cocaine and reducing cocaine\n      use in subjects with cocaine dependence."
        }, 
        "brief_title": "A Multi-Center Trial of Nepicastat for Cocaine Dependence", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cocaine Dependence", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Be at least 18 years of age\n\n          -  Is seeking treatment for cocaine dependence\n\n          -  Is able to understand and provide written informed consent\n\n          -  Has completed all psychological assessments and procedures required during the 7 - 14\n             day screening period\n\n          -  If female, agrees to use an acceptable method of birth control\n\n          -  Is, in the opinion of the Investigator, likely to complete the 11-week Treatment\n             Phase of the study\n\n        Exclusion Criteria:\n\n          -  Please contact the study site for more information"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01704196", 
            "org_study_id": "NIDA/VA CS#1031"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nepicastat", 
                "description": "120 mg of active drug and 100mg of riboflavin daily for 11 weeks or matching placebo containing 100mg of riboflavin daily for 11 weeks.", 
                "intervention_name": "Nepicastat", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 23, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90016"
                    }, 
                    "name": "Matrix Institute on Addictions"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92161"
                    }, 
                    "name": "VA San Diego Healthcare System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80220"
                    }, 
                    "name": "VA Medical Center - Denver, CO"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21229"
                    }, 
                    "name": "Mountain Manor Treatment Center at Baltimore"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albuquerque", 
                        "country": "United States", 
                        "state": "New Mexico", 
                        "zip": "87102"
                    }, 
                    "name": "Pacific Institute for Research and Evaluation"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10019"
                    }, 
                    "name": "Columbia University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45220"
                    }, 
                    "name": "Cincinnati Addiction Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "University of Pennsylvania - Treatment Research Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Michael E. DeBakey VA Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84148"
                    }, 
                    "name": "George E. Wahlen VA Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 2, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial of Nepicastat for Cocaine Dependence", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Subject will provide at least 2 urine samples within the given week.", 
            "measure": "Treatment success or failure", 
            "safety_issue": "No", 
            "time_frame": "Week 11"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01704196"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "A weekly mean urine BE level will be determine for each subject from the quantitative assay of BE values for each urine sample.", 
            "measure": "Weekly Mean Urine BE Level", 
            "safety_issue": "No", 
            "time_frame": "Up to 11 weeks"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}